Gynecological diseases
Conditions
Interventions
The group with no history of vaginal delivery:Oliceridine combined with propofol
The group with history of vaginal delivery:Oliceridine combined with propofol
Sponsors
Shaanxi 215 Hospital of nuclear industry
Eligibility
Sex/Gender
Female
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1.Female; 2.18~64 years old; 3.BMI:18.5~29.9 kg/m²; 4.ASA level I~II; 5.Patients diagnosed by a gynecologist as requiring hysteroscopy;
Exclusion criteria
Exclusion criteria: 1.Patients with a history of severe heart, brain, lung, liver, kidney, endocrine diseases and psychiatric-related diseases; 2.Heart rate< 50 beats per minute; 3.History of acute respiratory infection that has not been cured within 14 days, significant difficulty in the airway; 4.Patients with known hypersensitivity to propofol, oliceridine and their components; 5.Alcoholism, long-term use of sedatives or analgesics; 6.Patients with special hysteroscopic treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective dose of oliceridine fumarate injection; | — |
Secondary
| Measure | Time frame |
|---|---|
| baseline;vital signs;Adverse reactions;numerical rating scale scores;Propofol starting dose;Total dose of propofol;The amount of vasoactive drug used;Duration of surgery; | — |
Countries
China
Contacts
Public ContactLiuqin Jiang
Shaanxi 215 Hospital of nuclear industry
Outcome results
None listed